Versant Capital Management, Inc Glaukos Corp Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Glaukos Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 56 shares of GKOS stock, worth $8,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 99
43.43%
Holding current value
$8,765
Previous $12,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GKOS
# of Institutions
342Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$919 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$342 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$306 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$257 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.45B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...